Related Experiment Video

Updated: May 20, 2026

Induction of Accelerated Atherosclerosis in Mice: The "Wire-Injury" Model
05:35

Induction of Accelerated Atherosclerosis in Mice: The "Wire-Injury" Model

Published on: August 25, 2020

MicroRNAs and atherosclerosis: new actors for an old movie

D Santovito1, A Mezzetti, F Cipollone

  • 1European Center of Excellence on Atherosclerosis, Hypertension and Dyslipidemia, and Clinical Research Center - Center of Excellence on Aging (Ce.S.I.), G. d'Annunzio University, Chieti-Pescara, Italy.

Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|July 4, 2012
PubMed

Insights

MicroRNAs (miRNAs) are key regulators in cardiovascular diseases. This review explores their role in atherosclerosis, highlighting their potential as therapeutic targets for heart conditions.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • RNA Biology

Background:

  • Cardiovascular diseases (CVDs) are a major global health burden.
  • MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
  • Emerging evidence links miRNAs to cardiovascular development and diseases.

Purpose of the Study:

  • To review the role of miRNAs in atherosclerosis.
  • To identify miRNAs as potential therapeutic targets for atherosclerosis.

Main Methods:

  • Literature review of studies on miRNA and atherosclerosis.
  • Analysis of miRNA's involvement in cardiovascular diseases.
  • Exploration of therapeutic potential.

Main Results:

  • miRNAs significantly modulate cardiovascular development.
  • Specific miRNAs are implicated in atherosclerosis pathogenesis.
  • miRNAs influence various cardiovascular conditions including atherosclerosis.

Conclusions:

  • miRNAs play a critical role in the development and progression of atherosclerosis.
  • Targeting miRNAs offers a promising therapeutic strategy for cardiovascular diseases.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...